Healthy adult
Conditions
Interventions
Oral ingestion of target lactic acid bacteria for 2 weeks
Sponsors
Meiji Holdings Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Those who provided specimens in which target lactic acid bacteria increased the number of useful bacteria compared to the control in vitro 2.Those whose place of work is at Meiji Innovation Center at the time of obtaining consent 3.Those who have received sufficient explanation about the purpose and content of this study, have the ability to consent, fully volunteered with voluntary intention, agreed to participate
Exclusion criteria
Exclusion criteria: 1.Those who have participated in a study involving an intervention that is expected to affect our study, such as continuous consumption of foods expected to regulate the intestines during the month prior to screening, or those who plan to participate in a study involving a similar intervention during the period between screening and the end of the intake period. 2.Those who have a history of gastric or lower gastrointestinal tract surgery (excluding hemorrhoids and polypectomy) 3.Those who have a barium stomach X-ray, small or large intestine endoscopy, or bowel cleansing at a clinic or at home during the month prior to screening, or those who are scheduled to have these procedures during this study 4.Those who have taken, ingested, or used drugs that may affect the study (antibacterial agents [e.g., antibiotics], gastric acid secretion inhibitors [e.g., PPI], diabetes medications [e.g., metformin], laxatives [e.g., magnesium oxide], bile acid promoters [e.g., UDCA]) at least once a week during the month prior to screening, or who plan to take, ingest, or use these drugs at least once during the study 5.Those who plan to travel abroad, travel for more than one week, or go on a business trip during the period from one week prior to the intake period to the end of the intake period 6.Those with food allergies 7.Pregnant or lactating women 8.Subjects judged as unsuitable for the study by the principal investigator or research physician for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gut microbiota 2 weeks after intake | — |
Secondary
| Measure | Time frame |
|---|---|
| Mental health 2 weeks after intake | — |
Countries
Japan
Contacts
Public ContactSeiya Makino
Meiji Holdings Co., Ltd. Wellness Science Labs
Outcome results
None listed